Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

WHO experts warn against repeated boosters as strategy against COVID-19

January 12, 2022 Research and Development

Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …
News

MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis

January 12, 2022 Research and Development

Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …
News

Bharat Biotech receives approval to test nasal COVID-19 shot as booster

January 5, 2022 Research and Development

India’s drug regulator has granted approval to Bharat Biotech, for late stage trials of its nasal COVID-19 vaccine to be …
News

FDA grants breakthrough therapy designation to novel EGFR inhibitor

January 5, 2022 Research and Development

The FDA has granted a  breakthrough therapy designation to Cullian Oncology’s CLN-081, in certain patients with locally advanced or metastatic …
News

NaNotics and Mayo Clinic to collaborate on nanomedicine cancer treatment

January 5, 2022 Research and Development

Nanomedical company NaNotics have announced a research collaboration with Mayo Clinic, to develop a NaNot that targets the soluble form …
News
fahczjixoai9a8z

NICE recommends PONVORY for the treatment of relapsing forms of multiple sclerosis

January 5, 2022 Research and Development

NICE has issued a positive Final Appraisal Document (FAD) recommending PONVORY® (ponesimod) as an option in England and Wales for …
News

Avacta lateral flow test receives CE mark for consumer self-testing

December 22, 2021 Research and Development

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® …
News

South African study suggests Omicron has a lower risk of hospitalisation than Delta

December 22, 2021 Research and Development

A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …
News

FDA places clinical hold on use of injectable lenacapavir for HIV treatment

December 22, 2021 Research and Development

The FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials, in all ongoing clinical …
News
fgfwekgwyam8rvv

EMA recommends Nuvaxovid for authorisation, as WHO grants second Emergency Use Listing

December 22, 2021 Research and Development

Nuvaxovid™, the COVID-19 vaccine manufactured by the biotechnology company Novavax, has been listed for emergency use by WHO. The news …
News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021 Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …
News

Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies

December 15, 2021 Research and Development

Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …
News

Positive results in Phase III trial of candidemia and invasive candidiasis

December 15, 2021 Research and Development

Cidara Therapeutics and Mundipharma have announced positive topline data from the ReSTORE Phase III clinical trial, evaluating the efficacy and …
News

Sanofi and GSK announce positive booster data for COVID-19 vaccine candidate

December 15, 2021 Research and Development

Sanofi and GSK have announced positive preliminary booster data for their COVID-19 vaccine candidate, and continuation of their Phase III …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026